Bianca A W Hoeben

Summary

Affiliation: Radboud University Nijmegen Medical Centre
Country: The Netherlands

Publications

  1. doi request reprint PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    J Nucl Med 51:1076-83. 2010
  2. doi request reprint Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Int J Cancer 129:870-8. 2011
  3. doi request reprint Imaging of epidermal growth factor receptor expression in head and neck cancer with SPECT/CT and 111In-labeled cetuximab-F(ab')2
    Laura K van Dijk
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands and
    J Nucl Med 54:2118-24. 2013
  4. doi request reprint Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Acta Oncol 52:1257-71. 2013
  5. doi request reprint 18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    J Nucl Med 54:532-40. 2013

Detail Information

Publications5

  1. doi request reprint PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    J Nucl Med 51:1076-83. 2010
    ....
  2. doi request reprint Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Int J Cancer 129:870-8. 2011
    ..i., respectively). Our study suggests that, at optimal cetuximab imaging dose, (111) In-cetuximab can be used for visualization of EGFR expression in head-and-neck squamous cell carcinoma using SPECT...
  3. doi request reprint Imaging of epidermal growth factor receptor expression in head and neck cancer with SPECT/CT and 111In-labeled cetuximab-F(ab')2
    Laura K van Dijk
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands and
    J Nucl Med 54:2118-24. 2013
    ..The aim of this study was to develop and characterize the (111)In-cetuximab-F(ab')2 tracer to image EGFR targeting in vivo...
  4. doi request reprint Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Acta Oncol 52:1257-71. 2013
    ..In this context, we focus this review on the widely used PET tracer (18)F-FDG and PET tracers depicting hypoxia and proliferation; two well-known radiation resistance mechanisms...
  5. doi request reprint 18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    J Nucl Med 54:532-40. 2013
    ....